Today: 7 February 2026
Subscribe

Novo Nordisk Stock (NVO) in Focus on Dec. 24, 2025: Wegovy Pill Shockwave, Policy Tailwinds, and Analyst Forecasts

Novo Nordisk Stock (NVO) in Focus on Dec. 24, 2025: Wegovy Pill Shockwave, Policy Tailwinds, and Analyst Forecasts

Dec. 24, 2025 — Novo Nordisk A/S (NYSE: NVO) has snapped back into the market’s spotlight this week after U.S. regulators cleared a pill version of its blockbuster obesity drug Wegovy—an approval that investors and analysts see as a pivotal moment in the fast-evolving GLP‑1 weight-loss race. But the story driving Novo Nordisk stock today is bigger than a single FDA decision: it’s also about pricing and coverage policy in the U.S., and a global expansion battle—especially in India—where branded GLP‑1s are colliding with the prospect of cheaper generics in 2026. Novo Nordisk+2Reuters+2 NVO shares have been trading around the
24 December 2025
···
American Airlines Group (AAL) Stock News Today: What’s Moving Shares on Dec. 24, 2025, Plus Analyst Forecasts and 2026 Outlook

American Airlines Group (AAL) Stock News Today: What’s Moving Shares on Dec. 24, 2025, Plus Analyst Forecasts and 2026 Outlook

December 24, 2025 — American Airlines Group Inc. (NASDAQ: AAL) is entering a holiday-shortened Christmas Eve session with investors weighing a familiar airline-stock cocktail: strong seasonal travel demand, big strategy shifts in loyalty and premium cabins, and the ever-present reality of leverage, operating costs, and headline risk. As of the latest available trading data on Dec. 24, AAL was around $15.60 in early indications after a sharp move lower in the prior session. With U.S. equity markets closing early at 1:00 p.m. ET on Christmas Eve, liquidity can be thinner than usual—sometimes amplifying price swings in either direction. New York
24 December 2025
·
Waste Management (WM) Stock News on Dec. 24, 2025: Institutional Buys, Employee Trading Blackout, and a 2026 Dividend-and-Buyback Push

Waste Management (WM) Stock News on Dec. 24, 2025: Institutional Buys, Employee Trading Blackout, and a 2026 Dividend-and-Buyback Push

December 24, 2025 — Waste Management’s rebranded parent, WM (NYSE: WM), is ending 2025 with a familiar mix of defensive appeal and valuation debate—only now the story is getting sharper. On Dec. 24, 2025, fresh disclosures highlighted new institutional accumulation in the stock, while a company retirement-plan trading blackout begins today. At the same time, investors are still digesting WM’s “next chapter”: integrating Stericycle’s medical waste business, defending premium margins in its core operations, and setting up a 2026 capital-return program that includes a planned dividend increase and a $3 billion repurchase authorization. TradingView+4MarketBeat+4MarketBeat+4 Below is everything investors are watching—built
24 December 2025
··
Plug Power PLUG Stock News Today: Analyst Targets, Hydrogen Contracts, and Dilution Risks Ahead of the 2026 Shareholder Vote (Dec. 24, 2025)

Plug Power PLUG Stock News Today: Analyst Targets, Hydrogen Contracts, and Dilution Risks Ahead of the 2026 Shareholder Vote (Dec. 24, 2025)

Plug Power Inc. (NASDAQ: PLUG) is spending Christmas Eve in a familiar place for long-time shareholders: the intersection of big-horizon hydrogen ambition and hard-nosed capital markets reality. Shares recently hovered around the $2 level, after closing $2.05 on Dec. 23 (down 2.84%)—a valuation that puts Plug’s market cap at roughly $2.9 billion. The Motley Fool That low price point matters because it amplifies everything: every funding headline, every contract win, every policy wobble, every “is it finally turning?” debate. And on Dec. 24, 2025, that debate is loud—because today’s coverage includes both a fresh skepticism check and a rare “upgrade”
24 December 2025
·
Nike Stock Rises After Apple CEO Tim Cook Buys $3 Million Stake, Signaling Confidence in Turnaround Amid Tariffs and China Slowdown

Nike Stock Rises After Apple CEO Tim Cook Buys $3 Million Stake, Signaling Confidence in Turnaround Amid Tariffs and China Slowdown

NEW YORK — Nike shares traded higher on Wednesday, December 24, 2025, after a regulatory filing showed Apple CEO Tim Cook bought nearly $3 million worth of Nike stock, a notable insider purchase that investors quickly interpreted as a vote of confidence following a bruising post-earnings selloff. Reuters+1 Cook, who has served on Nike’s board since 2005 and is the company’s lead independent director, purchased 50,000 shares of Nike Class B common stock on December 22 at a weighted average price of $58.97, according to an SEC Form 4 filed on December 23. Reuters+2SEC+2 The disclosure helped lift Nike shares
24 December 2025
··
Scentre Group Sells 19.9% of Westfield Sydney to Australian Retirement Trust in A$864m Deal

Scentre Group Sells 19.9% of Westfield Sydney to Australian Retirement Trust in A$864m Deal

Scentre Group has agreed to sell a 19.9% stake in its flagship Westfield Sydney shopping centre to superannuation giant Australian Retirement Trust (ART) for A$864 million (about US$576 million), in a transaction priced at the asset’s June 2025 book value. Scentre will remain the majority owner and keep control of day-to-day operations, retaining an 80.1% interest and continuing as property, leasing and development manager. Scentre Group+1 On Wednesday, 24 December 2025, fresh details emerged on how ART plans to run the investment: Queensland-based institutional investor QIC will act as investment manager for ART’s new stake, while Scentre continues to manage
24 December 2025
·
Eos Energy Enterprises Stock (EOSE) Turns Volatile After Chair Transition News as Wall Street Reprices the 2026 Ramp

Eos Energy Enterprises Stock (EOSE) Turns Volatile After Chair Transition News as Wall Street Reprices the 2026 Ramp

Eos Energy Enterprises (NASDAQ: EOSE) is heading into the Christmas Eve session with fresh volatility on the tape. Shares closed Tuesday, December 23, 2025 at $11.96, down 7.21%, after the market digested a board leadership transition; pre-market indications early Wednesday, December 24 were modestly higher. With U.S. equities scheduled to close early at 1:00 p.m. ET on Dec. 24, thinner holiday liquidity can amplify price swings—especially for high-beta names like EOSE. StockAnalysis+1 What happened: Eos announces a board chair handoff effective year-end On December 22, 2025, Eos disclosed that Russ Stidolph, its non-executive Chair since 2018 and a long-time investor
24 December 2025
··
Strategy Inc Stock MSTR News and Forecasts for December 24, 2025: Cash Reserve Pivot, Bitcoin Pause, and Wall Street Targets

Strategy Inc Stock MSTR News and Forecasts for December 24, 2025: Cash Reserve Pivot, Bitcoin Pause, and Wall Street Targets

December 24, 2025 — Strategy Inc (Nasdaq: MSTR) is spending Christmas Eve with investors debating a simple but loaded question: is the company’s latest move a prudent de-risking… or a sign that the “leveraged Bitcoin proxy” era is maturing into something more complicated? Shares have been volatile this week, trading around the high-$150s as the market digests fresh disclosures showing no new Bitcoin purchases during the latest reporting window and a sharply higher U.S. dollar cash reserve built from equity sales. MarketBeat+2MarketBeat+2 At the same time, Executive Chairman Michael Saylor is trying to reframe the entire investment story—positioning Strategy not
24 December 2025
··
United States Antimony Corporation (UAMY) Stock: Today’s Move, Latest Contracts, Analyst Forecasts, and What Investors Are Watching on Dec. 24, 2025

United States Antimony Corporation (UAMY) Stock: Today’s Move, Latest Contracts, Analyst Forecasts, and What Investors Are Watching on Dec. 24, 2025

United States Antimony Corporation (NYSE American: UAMY) has become one of the most closely watched “critical minerals” stocks of 2025—partly because antimony has moved from obscure industrial input to strategic flashpoint, and partly because UAMY’s own contract wins and expansion plans have repeatedly jolted the share price. With U.S. markets trading through Wednesday, Dec. 24, 2025 (despite a federal-government closure order that didn’t change exchange schedules), liquidity and headlines are colliding in the classic year-end way: moves can look bigger, faster, and noisier than they would in mid-January. Reuters Below is what’s driving attention around UAMY stock today, what the
24 December 2025
·
AiRWA Inc (YYAI) Stock News, Forecasts and Analysis for Dec. 24, 2025: New 10‑Q, $15.69M Offering, and Why the Tape Is So Volatile

AiRWA Inc (YYAI) Stock News, Forecasts and Analysis for Dec. 24, 2025: New 10‑Q, $15.69M Offering, and Why the Tape Is So Volatile

December 24, 2025 — AiRWA Inc. (NASDAQ: YYAI) heads into the Christmas Eve session with the kind of “small-cap-on-a-capital-raise” price action that tends to keep both momentum traders and long-term investors glued to Level II. After closing around $0.98 on Dec. 23, YYAI traded around $1.01 pre-market on Dec. 24 on some platforms, underscoring just how jumpy liquidity can be when fresh filings and financing news hit within the same week. StockAnalysis+1 That volatility also shows up in the stock’s extreme 52-week range reported by major data providers (roughly $0.8635 to $264.42). Importantly, those “high” numbers can look surreal after
24 December 2025
Broadcom (AVGO) Stock News Today, Forecasts and Analysis for Dec. 24, 2025: AI Margins, Tariffs, Insider Moves and Valuation

Broadcom (AVGO) Stock News Today, Forecasts and Analysis for Dec. 24, 2025: AI Margins, Tariffs, Insider Moves and Valuation

Broadcom Inc. (NASDAQ: AVGO) enters Christmas Eve trading with investors still debating the same two questions that have defined the stock’s volatile December: how durable is the AI-driven demand surge—and how much profitability gets sacrificed to capture it? With U.S. equities markets scheduled to close early at 1:00 p.m. ET today, liquidity is thinner than usual, which can exaggerate moves in high-momentum names like Broadcom. New York Stock Exchange+1 As of the latest available quote on Dec. 24, Broadcom shares were hovering around the $349–$350 area, after a strong prior session. MarketWatch Why Broadcom stock is still a headline name
24 December 2025
··
Teva Stock News on Dec. 24, 2025: TEVA Rallies on S&P Credit Upgrade, $40 Price Target Hike, and Fresh Pipeline Catalysts

Teva Stock News on Dec. 24, 2025: TEVA Rallies on S&P Credit Upgrade, $40 Price Target Hike, and Fresh Pipeline Catalysts

Teva Pharmaceutical Industries Limited (NYSE: TEVA; TASE: TEVA) stock is finishing 2025 with unusual momentum for a company long labeled “just a generics maker.” On Dec. 24, 2025, TEVA is trading around the $31–$32 range after a sharp run-up over the past several weeks, with holiday-thinned markets now digesting a cluster of developments that bulls say strengthen Teva’s “pivot to growth” story—and bears say risk turning into a valuation trap. StockAnalysis+1 This is the key backdrop: credit conditions are improving, analysts are lifting targets, and Teva’s pipeline/biosimilars calendar is getting clearer—all while the company is still navigating the industry’s classic
24 December 2025
··
Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next

Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next

Rezolute, Inc. (Nasdaq: RZLT) is still in the spotlight on December 24, 2025, after a brutal mid-December selloff tied to its pivotal clinical trial news—and a wave of follow-on analyst downgrades, price-target resets, and investor-law-firm investigations. As of the latest available pricing around $2.42 per share, the stock is off its post-trial lows but remains dramatically below pre-readout levels, leaving investors weighing a simple question with complicated consequences: was sunRIZE a fatal blow, or a detour that shifts the story toward Rezolute’s next late-stage program? MarketBeat+1 Below is a complete, publication-ready breakdown of the current RZLT stock news, forecasts, and
24 December 2025
··
Chick-fil-A Set to Return to Portland in Early 2026 at Former Strip Club Near Mall 205, as Christmas Eve Dining Hours Go Top of Mind

Chick-fil-A Set to Return to Portland in Early 2026 at Former Strip Club Near Mall 205, as Christmas Eve Dining Hours Go Top of Mind

PORTLAND, Ore. — December 24, 2025. On a day when millions of Americans are asking the same practical question — “What’s open on Christmas Eve and Christmas Day?” — Portland is also buzzing about a very different kind of food-and-hours headline: Chick-fil-A is preparing to return to Portland proper for the first time in roughly two decades, with an early 2026 opening now being touted for a high-profile site in Southeast Portland. KGW The new restaurant is slated for the former Venue Gentleman’s Club property on Southeast Stark Street, just north of Mall 205 — a location that has already
24 December 2025
Dollarama Stock (TSX: DOL) Near Fresh Highs on Dec. 24, 2025: Earnings Momentum, Global Expansion, and a Valuation Test

Dollarama Stock (TSX: DOL) Near Fresh Highs on Dec. 24, 2025: Earnings Momentum, Global Expansion, and a Valuation Test

Dollarama is ending 2025 in the spotlight as investors weigh a familiar question with an unusually sharp edge: how much is too much to pay for a business that keeps delivering? On December 24, 2025, the discussion is unfolding against a holiday-thinned trading session in Canada—markets are scheduled to close early—after the S&P/TSX set new records and heads toward its best annual performance since 2009. Reuters At the stock level, Dollarama has been pressing toward the upper end of its recent range, closing around C$204.69 in the latest session cited by multiple market trackers—right where the latest valuation commentary is
24 December 2025
··
Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is in the spotlight on December 24, 2025 after a sharp selloff driven by a major regulatory development: the U.S. Food and Drug Administration recommended that Reviva run an additional Phase 3 trial for its lead schizophrenia candidate, brilaroxazine, before filing a New Drug Application (NDA). SEC+1 Shares were trading around $0.32 after the drop, reflecting how quickly biotech valuations can reprice when timelines and funding needs change—especially for micro-cap clinical-stage companies. StockAnalysis What happened to Reviva Pharmaceuticals stock on December 24, 2025? The core catalyst is a regulatory “reset” of the near-term approval
24 December 2025
···
Regencell Bioscience Holdings Limited (RGC) Stock: News, Forecasts, and Fresh Analysis for Dec. 24, 2025

Regencell Bioscience Holdings Limited (RGC) Stock: News, Forecasts, and Fresh Analysis for Dec. 24, 2025

Dec. 24, 2025 — Regencell Bioscience Holdings Limited (NASDAQ: RGC) is having one of those “stock market is a strange animal” moments again: the share price is moving sharply on a story dominated less by traditional fundamentals and more by market structure—low float, extreme volatility, and ongoing legal overhang. As of Dec. 24, 2025, RGC was trading around $25.25, up roughly 14% on the day. Below is a complete, publication-ready roundup of what’s new today (12/24/2025), what the most current forecasts/models are implying, and what the latest filings and third‑party analysis say about the risks that keep following this stock
24 December 2025
··
Stock Market Today: U.S. Futures Dip on Christmas Eve as S&P 500 Holds Record High and GDP Surprise Trims Rate‑Cut Bets

Stock Market Today: U.S. Futures Dip on Christmas Eve as S&P 500 Holds Record High and GDP Surprise Trims Rate‑Cut Bets

Wall Street is heading into Christmas Eve trading (Wednesday, December 24, 2025) with a familiar holiday mix: thin liquidity, an early close, and outsized market attention on macro headlines after the S&P 500 finished Tuesday at a fresh record. U.S. stock index futures were modestly lower in premarket action, as traders weighed an unexpectedly strong U.S. growth reading against stubborn inflation signals that are complicating the path for Federal Reserve rate cuts in 2026. Reuters+2Reuters+2 This year’s story has also been shaped by a unique wrinkle: several key government economic releases were delayed by a federal shutdown, meaning investors have
24 December 2025
Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth Corporation (NASDAQ: CGC, TSX: WEED) is ending 2025 with something cannabis stocks haven’t seen in a while: sustained, headline-driven volatility — the kind that can lift prices fast, then yank them back down just as quickly. As of Dec. 24, 2025, CGC was trading around $1.40 in U.S. markets, after closing at $1.40 on Dec. 23 and showing a modest uptick in early premarket indications. StockAnalysis That price tag doesn’t tell the story by itself. December’s story is about policy momentum in Washington, a fresh Canadian acquisition announcement, and a market that’s still trying to decide whether Canopy
24 December 2025
····
Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question

Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question

Indaptus Therapeutics, Inc. (NASDAQ: INDP) is getting unusual attention heading into December 24, 2025, after a late-December SEC filing laid out a $6.0 million preferred-stock financing, a boardroom reshuffle, and a new co-CEO / chairman appointment—a mix that can ignite short-term trading interest while also forcing investors to re-run the long-term share-count math. SEC+1 The key tension is straightforward: the deal injects capital into a clinical-stage biotech that has been funding itself through repeated capital raises, but it also introduces a preferred security that—if shareholders approve conversion—could translate into up to 111 million common shares. In micro-cap land, that number
24 December 2025
··
1 … 766 767 768 769 770 … 1,633

Stock Market Today

Go toTop